Tirzepatide × Licensed Peptides - Lab Test, February 2026
Test results
About this test
This independent HPLC-UV/VIS lab test confirms Tirzepatide 45mg from Licensed Peptides at >99.80% purity. The analysis was conducted by a third-party ISO 17025:2017 accredited laboratory and reported on February 20, 2026. The tested quantity measured 41.67 mg against a stated label claim of 45 mg.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its role in metabolic regulation, glycemic control, and weight management. Endotoxin testing passed at <5.00 EU/mg via the LAL method, and sterility testing via USP <71> confirmed no growth detected.
The full certificate of analysis and HPLC chromatogram are available for review on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.